Cargando…
Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmoti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689108/ https://www.ncbi.nlm.nih.gov/pubmed/38046527 http://dx.doi.org/10.1055/a-2103-8329 |
_version_ | 1785152302424784896 |
---|---|
author | Rath, Werner Kummer, Julia Königbauer, Josefine T. Hellmeyer, Lars Stelzl, Patrick |
author_facet | Rath, Werner Kummer, Julia Königbauer, Josefine T. Hellmeyer, Lars Stelzl, Patrick |
author_sort | Rath, Werner |
collection | PubMed |
description | Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmotic cervical dilators. Not until 2015, when Dilapan-S was approved by the Food and Drug Administration (FDA) for induction of labor, numerous studies have been published on the use of Dilapan-S in this field. The rate of vaginal deliveries associated with the use of Dilapan-S ranges from 61.6 to 81.7%, and no serious complications needing further interventions have been reported to this date. Dilapan-S was shown to be as effective as the Foley balloon catheter as well as the 10 mg PGE (2) vaginal insert and orally applied misoprostol (25 µg every 2 hours) in achieving vaginal delivery, but patient’s satisfaction during the cervical ripening process was significantly higher compared to the other methods and the rate of uterine hyperstimulation was significantly lower compared to prostaglandins (PGs). Minor complications (e.g. vaginal bleeding) associated with the use of Dilapan-S were < 2%, and maternal infectious morbidity was not higher compared to Foley balloon and vaginal PGE (2) or misoprostol. Due to these beneficial properties Dilapan-S might be an ideal option for outpatient cervical ripening, as shown in a recent randomized clinical trial comparing inpatient to outpatient cervical ripening. Furthermore, according to the manufacturers’ product information, Dilapan-S is the only cervical ripening method that is not contraindicated for induction of labor in women with a previous cesarean section. Upcoming guidelines should consider synthetic osmotic cervical dilators as an effective and safe method for cervical ripening/induction of labor acknowledging that more evidence-based data are mandatory, particularly in patients with a previous cesarean section. |
format | Online Article Text |
id | pubmed-10689108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-106891082023-12-01 Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review Rath, Werner Kummer, Julia Königbauer, Josefine T. Hellmeyer, Lars Stelzl, Patrick Geburtshilfe Frauenheilkd Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmotic cervical dilators. Not until 2015, when Dilapan-S was approved by the Food and Drug Administration (FDA) for induction of labor, numerous studies have been published on the use of Dilapan-S in this field. The rate of vaginal deliveries associated with the use of Dilapan-S ranges from 61.6 to 81.7%, and no serious complications needing further interventions have been reported to this date. Dilapan-S was shown to be as effective as the Foley balloon catheter as well as the 10 mg PGE (2) vaginal insert and orally applied misoprostol (25 µg every 2 hours) in achieving vaginal delivery, but patient’s satisfaction during the cervical ripening process was significantly higher compared to the other methods and the rate of uterine hyperstimulation was significantly lower compared to prostaglandins (PGs). Minor complications (e.g. vaginal bleeding) associated with the use of Dilapan-S were < 2%, and maternal infectious morbidity was not higher compared to Foley balloon and vaginal PGE (2) or misoprostol. Due to these beneficial properties Dilapan-S might be an ideal option for outpatient cervical ripening, as shown in a recent randomized clinical trial comparing inpatient to outpatient cervical ripening. Furthermore, according to the manufacturers’ product information, Dilapan-S is the only cervical ripening method that is not contraindicated for induction of labor in women with a previous cesarean section. Upcoming guidelines should consider synthetic osmotic cervical dilators as an effective and safe method for cervical ripening/induction of labor acknowledging that more evidence-based data are mandatory, particularly in patients with a previous cesarean section. Georg Thieme Verlag KG 2023-07-07 /pmc/articles/PMC10689108/ /pubmed/38046527 http://dx.doi.org/10.1055/a-2103-8329 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Rath, Werner Kummer, Julia Königbauer, Josefine T. Hellmeyer, Lars Stelzl, Patrick Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title | Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title_full | Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title_fullStr | Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title_full_unstemmed | Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title_short | Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review |
title_sort | synthetic osmotic dilators for pre-induction cervical ripening – an evidence-based review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689108/ https://www.ncbi.nlm.nih.gov/pubmed/38046527 http://dx.doi.org/10.1055/a-2103-8329 |
work_keys_str_mv | AT rathwerner syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview AT kummerjulia syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview AT konigbauerjosefinet syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview AT hellmeyerlars syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview AT stelzlpatrick syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview |